Mankind Pharma Profile
Key Indicators
- Authorised Capital ₹ 41.35 Cr
as on 23-06-2024
- Paid Up Capital ₹ 40.06 Cr
as on 23-06-2024
- Company Age 33 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 905.00 Cr
as on 23-06-2024
- Satisfied Charges ₹ 1,296.87 Cr
as on 23-06-2024
- Revenue 11.73%
(FY 2023)
- Profit -6.51%
(FY 2023)
- Ebitda -5.68%
(FY 2023)
- Net Worth 28.26%
(FY 2023)
- Total Assets 11.39%
(FY 2023)
About Mankind Pharma
The Corporate was formerly known as Mankind Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 41.35 Cr and a paid-up capital of Rs 40.06 Cr.
The company currently has active open charges totaling ₹905.00 Cr. The company has closed loans amounting to ₹1,296.87 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Mankind Pharma Limited India are Ashutosh Dhawan as Cfo, Sheetal Arora as Ceo, and Pradeep Chugh as Company Secretary. Surendra Lunia, Ramesh Juneja, Rajeev Juneja, and Six other members serve as directors at the Company.
- CIN/LLPIN
L74899DL1991PLC044843
- Company No.
044843
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Jul 1991
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mankind Pharma Limited offer?
Mankind Pharma Limited offers a wide range of products and services, including Sexual Wellness, Condoms, Women Care, Mother Care.
Who are the key members and board of directors at Mankind Pharma?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashutosh Dhawan  | CFO | 17-Jun-2016 | Current |
| Rajeev Juneja | Managing Director | 22-Dec-1992 | Current |
| Sheetal Arora | CEO | 20-May-2021 | Current |
| Pradeep Chugh | Company Secretary | 23-Sep-2016 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijaya Sampath | Director | 01-Aug-2022 | Current |
| Surendra Lunia | Director | 19-Feb-2015 | Current |
| Satish Sharma | Whole-Time Director | 23-Sep-2016 | Current |
Bharat Anand  | Director | 31-Aug-2018 | Current |
| Ramesh Juneja | Whole-Time Director | 03-Jul-1991 | Current |
Vivek Kalra  | Director | 01-Aug-2022 | Current |
Financial Performance of Mankind Pharma.
Mankind Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.73% increase. The company also saw a slight decrease in profitability, with a 6.51% decrease in profit. The company's net worth Soared by an impressive increase of 28.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mankind Pharma?
In 2022, Mankind Pharma had a promoter holding of 79.00% and a public holding of 21.00%. The company had 21 Subsidiaries and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Dec 2023 | ₹180.00 Cr | Open |
Others Creation Date: 30 Mar 2021 | ₹170.00 Cr | Open |
Hdfc Bank Limited Creation Date: 11 Dec 2020 | ₹250.00 Cr | Open |
How Many Employees Work at Mankind Pharma?
Mankind Pharma has a workforce of 19014 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mankind Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mankind Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
